Study Published in Journal of Clinical Microbiology Reports the Sensitivity and Specificity of Great Basin Corporation’s Clostridium difficile Molecular Diagnostic Test
12:35 EDT 13 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
A study published in the August issue of Journal of Clinical
Microbiology showed that Great Basin Corporation’s toxigenic Clostridium
difficile (C. diff) molecular diagnostic test has a 97
percent sensitivity and 100 percent s...
Other Sources for this Article
Great Basin Corporation
Sandra Nielsen, 801-990-1055
snielsen@gbscience.com
or
Edelman
Jennifer
Chan, 415-229-7650
Jennifer.chan@edelman.com
More From BioPortfolio on "Study Published in Journal of Clinical Microbiology Reports the Sensitivity and Specificity of Great Basin Corporation’s Clostridium difficile Molecular Diagnostic Test"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
